Cancer Prevention Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Current Issue

Volume 15,

Issue 10

1 October 2022

View This Issue

About the Journal

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Read More About the Journal

Editors-in-Chief

Raymond N. DuBois
Michael N. Pollak

View Full Editorial Board

Impact Factor

3.296

SUBMIT TO JOURNAL

Featured Articles

Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial

Takuma Higurashi, et al.

Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition

Suzanne P. MacFarland, et al.

Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial

Katherine D. Crew, et al.

Trending - Altmetric

Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort

Last mentioned on Tuesday October 4 2022

The Impact of Tonsillectomy upon the Risk of Oropharyngeal Carcinoma Diagnosis and Prognosis in the Danish Cancer Registry

Last mentioned on Tuesday October 4 2022

Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features

Last mentioned on Tuesday October 4 2022

Targeting the Leukotriene Pathway for Colon Cancer Interception

Last mentioned on Tuesday October 4 2022

Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial

Last mentioned on Tuesday October 4 2022

Latest
Most Read
Most Cited

Transcriptomic Response to Calcium in Normal Colon Organoids is Impacted by Colon Location and Sex

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population

Association of Plasma Iron Status with Subsequent Risk of Total and Site-Specific Cancer: A Large Case–Cohort Study within JPHC Study

Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial

Tweets by CAPR_AACR

Issues
Online First
News

Twitter

Online ISSN 1940-6215
Print ISSN 1940-6207

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept